[HTML][HTML] A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

…, J Batra, K Haas, M Modak, M Kim, P Haas… - Nature, 2020 - nature.com
A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which is the causative agent of coronavirus disease 2019 (COVID-19), has …

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

…, U Rathore, M Modak, P Haas, KM Haas… - Science, 2020 - science.org
INTRODUCTION The emergence of three lethal coronaviruses in <20 years and the urgency
of the COVID-19 pandemic have prompted efforts to develop new therapeutic strategies, …

[HTML][HTML] A functional map of HIV-host interactions in primary human T cells

…, RT Leenay, LM Simons, JM Young, P Haas… - Nature …, 2022 - nature.com
Human Immunodeficiency Virus (HIV) relies on host molecular machinery for replication.
Systematic attempts to genetically or biochemically define these host factors have yielded …

[PDF][PDF] Protein interaction mapping identifies RBBP6 as a negative regulator of Ebola virus replication

…, A Reyes, DW Leung, R Kaake, P Haas… - Cell, 2018 - cell.com
Ebola virus (EBOV) infection often results in fatal illness in humans, yet little is known about
how EBOV usurps host pathways during infection. To address this, we used affinity tag-…

CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions

…, J Hiatt, K Schumann, MJ McGregor, TL Roth, P Haas… - Nature protocols, 2019 - nature.com
CRISPR–Cas9 gene-editing strategies have revolutionized our ability to engineer the
human genome for robust functional interrogation of complex biological processes. We have …

Proteomic approaches to study SARS-CoV-2 biology and COVID-19 pathology

P Haas, M Muralidharan, NJ Krogan… - Journal of proteome …, 2021 - ACS Publications
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative
agent of coronavirus disease 2019 (COVID-19), was declared a pandemic infection in March …

Transcriptional correlates of malaria in RTS, S/AS01-vaccinated African children: a matched case–control study

…, A Nhabomba, M Mpina, C Jairoce, G Finak, P Haas… - Elife, 2022 - elifesciences.org
Background: In a phase 3 trial in African infants and children, the RTS, S/AS01 vaccine (GSK)
showed moderate efficacy against clinical malaria. We sought to further understand RTS, S…

[PDF][PDF] Chemogenetic characterization of inositol phosphate metabolic pathway reveals druggable enzymes for targeting kinetoplastid parasites

I Cestari, P Haas, NS Moretti, S Schenkman… - Cell chemical biology, 2016 - cell.com
Kinetoplastids cause Chagas disease, human African trypanosomiasis, and leishmaniases.
Current treatments for these diseases are toxic and inefficient, and our limited knowledge of …

CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells

U Rathore, P Haas, V Easwar Kumar, J Hiatt, KM Haas… - Mbio, 2024 - Am Soc Microbiol
HIV, the virus that causes AIDS, heavily relies on the machinery of human cells to infect and
replicate. Our study focuses on the host cell’s ubiquitination system which is crucial for …

A baseline transcriptional signature associates with clinical malaria risk in RTS, S/AS01-vaccinated African children

…, AJ Nhabomba, M Mpina, C Jairoce, G Finak, P Haas… - medRxiv, 2021 - medrxiv.org
In a phase 3 trial in African infants/children, the RTS,S/AS01 (GSK) vaccine showed moderate
efficacy against clinical malaria. We aimed to identify RTS,S/AS01-induced signatures …